Oxford Science Enterprises
Oxford Science Enterprises a university-partnered venture firm, investing in early-stage life science, AI &a; software, and deep tech.
Business Model: B2B
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Oxford Science Enterprises Information
Geographic Data
Address: 46 Woodstock Road
City: Oxford
State: england
Zip: OX2 6HT
Country: GB
Financial Info
Stage:
Raised Last:
$299M
Raised Total:$300M
Social
Twitter
Linkedin
Crunchbase
Metrics
4,299,602Website Global Rank
2,884Website Monthly Traffic
Twitter Followers
Description
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 6/2017 | Scenic Biotech | Series A | 7.3M |
| 12/2018 | Genomics | Series B | 9.1M |
| 5/2021 | Omega Crop | Seed Round | 1.7M |
| 1/2018 | Pepgen | Seed Round | - |
| 3/2021 | Genomics | Venture Round | 30M |
| 1/2020 | OxMet Technologies | Series B | 14.1M |
| 1/2016 | Mixergy Ltd. | Seed Round | - |
| 11/2015 | Bodle Technologies | Seed Round | - |
| 11/2017 | Quantum Motion Technologies | Seed Round | - |
| 7/2021 | Orbit Discovery | Venture Round | 0 |
| 10/2016 | Argonaut Therapeutics | Seed Round | - |
| 7/2019 | Zegami | Series B | 1.6M |
| 4/2020 | BibliU | Series A | 10M |
| 12/2021 | ONI | Series B | 75M |
| 12/2016 | Circadian Therapeutics | Venture Round | 2.5M |
| 6/2015 | OxStem | Seed Round | - |
| 6/2018 | BibliU | Seed Round | 3.8M |
| 3/2018 | Xerion Healthcare | Venture Round | 2.8M |
| 3/2022 | Scenic Biotech | Series A | 0 |
| 1/2017 | Covatic | Seed Round | 896.6k |
| 3/2021 | Caristo Diagnostics | Venture Round | - |
| 6/2018 | Metaboards | Series A | 0 |
| 2/2017 | BibliU | Seed Round | 1.4M |
| 7/2020 | PQShield | Seed Round | 6.9M |
| 7/2018 | ONI | Series A | 24M |
| 2/2020 | Oxford VR | Series A | 0 |
| 12/2022 | BehaVR | Series B | 0 |
| 10/2018 | Caristo Diagnostics | Seed Round | 2.6M |
| 4/2018 | Oxford Flow | Venture Round | 8.5M |
| 7/2016 | Oxford Impedance Diagnostics Ltd. | Seed Round | 2.6M |
| 1/2021 | Living Optics | Seed Round | 0 |
| 8/2019 | MoA Technology | Series A | 7.6M |
| 5/2018 | Orbit Discovery | Series A | 0 |
| 11/2017 | First Light Fusion | Venture Round | - |
| 1/2017 | Oxford VR | Seed Round | - |
| 10/2018 | Animal Dynamics | Series A | 0 |
| 5/2018 | Ultromics | Series A | 0 |
| 6/2022 | BibliU | Series B | 0 |
| 9/2018 | Evox Therapeutics | Series B | 0 |
| 12/2021 | Navenio | Venture Round | 0 |
| 7/2019 | Zegami | Series B | 1.6M |
| 11/2022 | Util | Seed Round | 0 |
| 6/2020 | Base Genomics | Seed Round | 11.3M |
| 7/2021 | Rey | Series A | 10M |
| 4/2023 | Caristo Diagnostics | Series A | 0 |
| 3/2023 | Mixergy | Venture Round | 0 |
| 3/2023 | Quantrol Ox | Seed Round | 0 |
| 2/2023 | Archangel Lightworks | Seed Round | 0 |
| 1/2023 | Grey Wolf Therapeutics | Series B | 0 |
| 5/2018 | Opsydia | Seed Round | 2.5M |
| 6/2022 | MiroBio | Series B | 0 |
| 6/2023 | Beacon Therapeutics | Series A | 0 |
| 7/2020 | ORCA Computing | Pre Seed Round | - |
| 2/2018 | Odqa Renewable Energy Technologies | Seed Round | 570.6k |
| 12/2019 | Mixergy Ltd. | Series A | 0 |
| 9/2022 | Opsydia | Venture Round | 0 |
| 5/2016 | ONI | Seed Round | 1.7M |
| 10/2019 | MiroBio | Series A | 33.2M |
| 6/2020 | Oxford Flow | Venture Round | 0 |
| 4/2020 | Perspectum | Series B | 35.9M |
| 5/2018 | PQShield | Seed Round | - |
| 2/2018 | Latent Logic | Seed Round | 2M |
| 8/2017 | Inkpath | Series A | - |
| 2/2021 | Evox Therapeutics | Series C | 96.7M |
| 6/2019 | Oxford Semantic Technologies | Series A | 3.8M |
| 5/2018 | Util | Seed Round | 1.1M |
| 3/2021 | Vaccitech | Series B | 168M |
| 1/2023 | Amber Therapeutics | Seed Round | - |
| 10/2018 | Covatic | Seed Round | 1.1M |
| 12/2020 | DJS Antibodies | Venture Round | 0 |
| 3/2017 | Bodle Technologies | Seed Round | - |
| 6/2015 | Proxisense | Seed Round | - |
| 9/2016 | Iota Sciences | Seed Round | - |
| 11/2017 | Albus Health | Convertible Note | 66.6k |
| 1/2022 | PQShield | Series A | 0 |
| 12/2020 | Pepgen | Series A | 45M |
| 6/2017 | Diffblue | Series A | 21.8M |
| 8/2021 | Pepgen | Venture Round | 0 |
| 12/2015 | Navenio | Seed Round | 2.6M |
| 2/2020 | OMass Technologies | Series A | 35.8M |
| 5/2022 | Salience Labs | Seed Round | 11.5M |
| 11/2018 | OMass Technologies | Series A | 17.9M |
| 6/2016 | OMass Technologies | Seed Round | 1.4M |
| 1/2018 | Bodle Technologies | Series A | 8.5M |
| 12/2020 | T-Cypher Bio | Seed Round | - |
| 7/2022 | Brill Power | Series A | 0 |
| 3/2017 | SpyBiotech | Seed Round | 5M |
| 1/2023 | Oxford Ionics | Series A | 0 |
| 9/2011 | Oxtex | Seed Round | 800k |
| 11/2018 | OxMet Technologies | Series A | 7.8M |
| 2/2016 | Mind Foundry | Seed Round | 1.7M |
| 1/2018 | Vaccitech | Series A | 0 |
| 1/2021 | Theolytics | Series A | 6.8M |
| 6/2017 | Zegami | Series A | 3M |
| 11/2022 | Osler Diagnostics | Series C | 0 |
| 10/2022 | Nucleome Therapeutics | Series A | 42.3M |
| 9/2018 | Oxford VR | Seed Round | 4.2M |
| 9/2017 | Oxford Quantum Circuits | Series A | - |
| 4/2017 | ONI | Seed Round | 3.7M |
| 3/2018 | 6D.ai | Seed Round | - |
| 8/2018 | Genomics | Series B | 32.5M |
| 4/2020 | Living Optics | Seed Round | 4.1M |
| 3/2017 | Pro-Mapp | Seed Round | - |
| 5/2022 | MoA Technology | Series B | 0 |
| 9/2017 | Mind Foundry | Seed Round | 3.4M |
| 2/2021 | SpyBiotech | Series A | 32.5M |
| 4/2021 | Oxford Endovascular | Series A | 0 |
| 8/2021 | Ultromics | Series B | 0 |
| 11/2020 | Refeyn | Series A | 30M |
| 9/2019 | YASA | Series C | 22.2M |
| 12/2017 | Navenio | Funding Round | 7.7M |
| 2/2023 | Quantum Motion | Series B | 0 |
| 5/2020 | Navenio | Series A | 0 |
| 8/2018 | BioBeats | Seed Round | 3M |
| 5/2020 | Quantum Motion Technologies | Series A | 9.8M |
| 4/2022 | OMass Technologies | Series B | 0 |
| 11/2016 | Vaccitech | Seed Round | 12.4M |
| 12/2017 | Theolytics | Seed Round | 3.4M |
| 5/2017 | Ultromics | Seed Round | 2.6M |
| 8/2017 | OxMet Technologies | Seed Round | 2.6M |
| 5/2016 | Evox Therapeutics | Series A | 14.4M |
| 2/2022 | First Light Fusion | Series C | 45M |
| 6/2020 | Oxford Ionics | Seed Round | 3.4M |
| 12/2021 | Alethiomics | Seed Round | 8M |
| 1/2016 | Oxford Flow | Seed Round | - |
| 12/2016 | EnzBond | Seed Round | 445.3k |
| 10/2016 | DJS Antibodies | Seed Round | - |
| 6/2022 | ORCA Computing | Series A | 15M |
| 9/2018 | Oxford VR | Venture Round | 4.2M |
| 5/2019 | Albus Health | Convertible Note | 580.9k |
| 3/2017 | Oxford Semantic Technologies | Seed Round | - |
| 3/2016 | Diffblue | Seed Round | - |
| 7/2022 | Oxford Quantum Circuits | Series A | 45.4M |
| 8/2018 | Edplus | Pre Seed Round | 643.5k |
| 4/2023 | Caristo Diagnostics | Series A | 0 |
| 3/2023 | Mixergy | Venture Round | 0 |
| 3/2023 | Quantrol Ox | Seed Round | 0 |
| 2/2023 | Quantum Motion | Series B | 0 |
| 2/2023 | Archangel Lightworks | Seed Round | 0 |
| 1/2023 | Grey Wolf Therapeutics | Series B | 0 |
| 1/2023 | Amber Therapeutics | Seed Round | - |
| 1/2023 | Oxford Ionics | Series A | 0 |
| 12/2022 | BehaVR | Series B | 0 |
| 11/2022 | Osler Diagnostics | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
